Artiva Biotherapeutics, Inc. ARTV
NASDAQ · United States · Health Technology
$7.05-0.07 (-0.98%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.63 | -0.63 | -0.8% | $0 | — | -2.8%$11.59→$11.27 |
| Q1 2026 | 2026-05-08 | -0.95 | -0.84 | -13.1% | — | — | -15.3%$12.52→$10.60 |
| Q4 2025 | 2026-03-10 | -0.84 | -0.80 | -5.0% | — | — | +24.9%$5.71→$7.13 |
| Q3 2025 | 2025-11-12 | -0.88 | -0.92 | +4.3% | — | — | -5.6%$3.59→$3.39 |
| Q2 2024 | 2024-08-29 | -0.64 | -1.59 | +59.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.